Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamera J Corte

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Heart (British Cardiac Society)|November 5, 2013
Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT studyEdmund Mt Lau, Dale L Bailey, Elizabeth A Bailey, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 28, 2021
Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in AustraliaIngrid A Cox, Barbara de Graaff, Tamera J Corte, et al.
ERJ Open Research|March 5, 2025
Incidence and survival of interstitial lung diseases in the UK in 2010-2019Francesca Gonnelli, Neva Eleangovan, Ursie Smith, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 4, 2022
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8DIngrid A Cox, Julie Campbell, Barbara de Graaff, et al.
Proteomics. Clinical Applications|February 13, 2021
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosisShabarinath Nambiar, Dino Bee Aik Tan, Britt Clynick, et al.
Rheumatology (Oxford, England)|February 17, 2024
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosisMatthew James Sinclair Parker, Adelle S Jee, Dylan Hansen, et al.
Respirology (Carlton, Vic.)|August 9, 2019
Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosisYuben P Moodley, Tamera J Corte, Brian G Oliver, et al.
Annals of the American Thoracic Society|June 30, 2021
Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi SurveyAlan K Y Teoh, Anne E Holland, Julie Morisset, et al.
Respirology (Carlton, Vic.)|December 22, 2021
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in AustraliaIngrid A Cox, Petr Otahal, Barbara de Graaff, et al.
Respirology (Carlton, Vic.)|September 12, 2017
The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaJyotika D Prasad, Annabelle Mahar, Jane Bleasel, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Heart (British Cardiac Society)|November 5, 2013
Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT studyEdmund Mt Lau, Dale L Bailey, Elizabeth A Bailey, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 28, 2021
Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in AustraliaIngrid A Cox, Barbara de Graaff, Tamera J Corte, et al.
ERJ Open Research|March 5, 2025
Incidence and survival of interstitial lung diseases in the UK in 2010-2019Francesca Gonnelli, Neva Eleangovan, Ursie Smith, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 4, 2022
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8DIngrid A Cox, Julie Campbell, Barbara de Graaff, et al.
Proteomics. Clinical Applications|February 13, 2021
Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosisShabarinath Nambiar, Dino Bee Aik Tan, Britt Clynick, et al.
Rheumatology (Oxford, England)|February 17, 2024
Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosisMatthew James Sinclair Parker, Adelle S Jee, Dylan Hansen, et al.
Respirology (Carlton, Vic.)|August 9, 2019
Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosisYuben P Moodley, Tamera J Corte, Brian G Oliver, et al.
Annals of the American Thoracic Society|June 30, 2021
Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi SurveyAlan K Y Teoh, Anne E Holland, Julie Morisset, et al.
Respirology (Carlton, Vic.)|December 22, 2021
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in AustraliaIngrid A Cox, Petr Otahal, Barbara de Graaff, et al.
Respirology (Carlton, Vic.)|September 12, 2017
The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaJyotika D Prasad, Annabelle Mahar, Jane Bleasel, et al.
Pageof 16